Risk factors and incidence of de novo malignancy in liver transplant recipients: A systematic review

Eric W Chak, Sammy Saab

Research output: Contribution to journalReview article

71 Citations (Scopus)

Abstract

Orthotopic liver transplant (OLT) is an established life saving procedure for both acute and chronic liver failure, but incidences and risk factors for development of these malignancies are yet to be established. To determine the incidences and risk factors associated with de novo malignancy after OLT. We performed a systematic review of relevant epidemiological studies available on MEDLINE, which provided information on the incidences and risk factors for the development malignancies in adult OLT recipients published from 1983 to 2009. All data was compiled from retrospective studies. Independent risk factors for the development of de novo malignancy in adult OLT recipients were identified to be statistically significant including immunosuppression, hepatitis C virus infection, smoking, alcoholic cirrhosis and sun exposure. OLT recipients with smoking and alcohol history are of particular risk for head and neck and lung cancers. Primary sclerosing cholangitis and inflammatory bowel disease were found to be independent risk factors for colon cancer. Adult OLT recipients are at increased risk for the development of post-transplant malignancies and obviates the need for surveillance protocols that are safe and cost-effective. OLT recipients should be advised on taking proper precautions in the sun, smoking cessation, and eliminating alcohol consumption. Given the emergence of alcoholic cirrhosis as a leading indication for liver transplantation, the early detection of lung and head and neck cancers is of particular importance.

Original languageEnglish (US)
Pages (from-to)1247-1258
Number of pages12
JournalLiver International
Volume30
Issue number9
DOIs
StatePublished - Oct 2010

Fingerprint

Liver
Incidence
Neoplasms
Alcoholic Liver Cirrhosis
Solar System
Head and Neck Neoplasms
Transplants
Lung Neoplasms
Smoking
Sclerosing Cholangitis
End Stage Liver Disease
Acute Liver Failure
Virus Diseases
Smoking Cessation
Transplant Recipients
Inflammatory Bowel Diseases
MEDLINE
Alcohol Drinking
Hepacivirus
Liver Transplantation

Keywords

  • De novo malignancy
  • Liver transplantation

ASJC Scopus subject areas

  • Hepatology

Cite this

Risk factors and incidence of de novo malignancy in liver transplant recipients : A systematic review. / Chak, Eric W; Saab, Sammy.

In: Liver International, Vol. 30, No. 9, 10.2010, p. 1247-1258.

Research output: Contribution to journalReview article

@article{39829188b7724391824fe015dc1edcf6,
title = "Risk factors and incidence of de novo malignancy in liver transplant recipients: A systematic review",
abstract = "Orthotopic liver transplant (OLT) is an established life saving procedure for both acute and chronic liver failure, but incidences and risk factors for development of these malignancies are yet to be established. To determine the incidences and risk factors associated with de novo malignancy after OLT. We performed a systematic review of relevant epidemiological studies available on MEDLINE, which provided information on the incidences and risk factors for the development malignancies in adult OLT recipients published from 1983 to 2009. All data was compiled from retrospective studies. Independent risk factors for the development of de novo malignancy in adult OLT recipients were identified to be statistically significant including immunosuppression, hepatitis C virus infection, smoking, alcoholic cirrhosis and sun exposure. OLT recipients with smoking and alcohol history are of particular risk for head and neck and lung cancers. Primary sclerosing cholangitis and inflammatory bowel disease were found to be independent risk factors for colon cancer. Adult OLT recipients are at increased risk for the development of post-transplant malignancies and obviates the need for surveillance protocols that are safe and cost-effective. OLT recipients should be advised on taking proper precautions in the sun, smoking cessation, and eliminating alcohol consumption. Given the emergence of alcoholic cirrhosis as a leading indication for liver transplantation, the early detection of lung and head and neck cancers is of particular importance.",
keywords = "De novo malignancy, Liver transplantation",
author = "Chak, {Eric W} and Sammy Saab",
year = "2010",
month = "10",
doi = "10.1111/j.1478-3231.2010.02303.x",
language = "English (US)",
volume = "30",
pages = "1247--1258",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Risk factors and incidence of de novo malignancy in liver transplant recipients

T2 - A systematic review

AU - Chak, Eric W

AU - Saab, Sammy

PY - 2010/10

Y1 - 2010/10

N2 - Orthotopic liver transplant (OLT) is an established life saving procedure for both acute and chronic liver failure, but incidences and risk factors for development of these malignancies are yet to be established. To determine the incidences and risk factors associated with de novo malignancy after OLT. We performed a systematic review of relevant epidemiological studies available on MEDLINE, which provided information on the incidences and risk factors for the development malignancies in adult OLT recipients published from 1983 to 2009. All data was compiled from retrospective studies. Independent risk factors for the development of de novo malignancy in adult OLT recipients were identified to be statistically significant including immunosuppression, hepatitis C virus infection, smoking, alcoholic cirrhosis and sun exposure. OLT recipients with smoking and alcohol history are of particular risk for head and neck and lung cancers. Primary sclerosing cholangitis and inflammatory bowel disease were found to be independent risk factors for colon cancer. Adult OLT recipients are at increased risk for the development of post-transplant malignancies and obviates the need for surveillance protocols that are safe and cost-effective. OLT recipients should be advised on taking proper precautions in the sun, smoking cessation, and eliminating alcohol consumption. Given the emergence of alcoholic cirrhosis as a leading indication for liver transplantation, the early detection of lung and head and neck cancers is of particular importance.

AB - Orthotopic liver transplant (OLT) is an established life saving procedure for both acute and chronic liver failure, but incidences and risk factors for development of these malignancies are yet to be established. To determine the incidences and risk factors associated with de novo malignancy after OLT. We performed a systematic review of relevant epidemiological studies available on MEDLINE, which provided information on the incidences and risk factors for the development malignancies in adult OLT recipients published from 1983 to 2009. All data was compiled from retrospective studies. Independent risk factors for the development of de novo malignancy in adult OLT recipients were identified to be statistically significant including immunosuppression, hepatitis C virus infection, smoking, alcoholic cirrhosis and sun exposure. OLT recipients with smoking and alcohol history are of particular risk for head and neck and lung cancers. Primary sclerosing cholangitis and inflammatory bowel disease were found to be independent risk factors for colon cancer. Adult OLT recipients are at increased risk for the development of post-transplant malignancies and obviates the need for surveillance protocols that are safe and cost-effective. OLT recipients should be advised on taking proper precautions in the sun, smoking cessation, and eliminating alcohol consumption. Given the emergence of alcoholic cirrhosis as a leading indication for liver transplantation, the early detection of lung and head and neck cancers is of particular importance.

KW - De novo malignancy

KW - Liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=78349266826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349266826&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2010.02303.x

DO - 10.1111/j.1478-3231.2010.02303.x

M3 - Review article

C2 - 20602682

AN - SCOPUS:78349266826

VL - 30

SP - 1247

EP - 1258

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 9

ER -